BioCryst Pharmaceuticals Inc
NASDAQ:BCRX

Watchlist Manager
BioCryst Pharmaceuticals Inc Logo
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Watchlist
Price: 7.45 USD -2.49% Market Closed
Market Cap: 1.5B USD
Have any thoughts about
BioCryst Pharmaceuticals Inc?
Write Note

BioCryst Pharmaceuticals Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BioCryst Pharmaceuticals Inc
PP&E Net Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
PP&E Net
$7.7m
CAGR 3-Years
-16%
CAGR 5-Years
-7%
CAGR 10-Years
44%
Abbvie Inc
NYSE:ABBV
PP&E Net
$5.1B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Net
$5.4B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
14%
Amgen Inc
NASDAQ:AMGN
PP&E Net
$6.2B
CAGR 3-Years
7%
CAGR 5-Years
3%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Net
$2.5B
CAGR 3-Years
23%
CAGR 5-Years
26%
CAGR 10-Years
13%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Net
$4.4B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
18%

See Also

What is BioCryst Pharmaceuticals Inc's PP&E Net?
PP&E Net
7.7m USD

Based on the financial report for Sep 30, 2024, BioCryst Pharmaceuticals Inc's PP&E Net amounts to 7.7m USD.

What is BioCryst Pharmaceuticals Inc's PP&E Net growth rate?
PP&E Net CAGR 10Y
44%

Over the last year, the PP&E Net growth was -62%. The average annual PP&E Net growth rates for BioCryst Pharmaceuticals Inc have been -16% over the past three years , -7% over the past five years , and 44% over the past ten years .

Back to Top